Darya Chudova - 09 Sep 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
09 Sep 2024
Net transactions value
-$29,950
Form type
4
Filing time
10 Sep 2024, 16:58:35 UTC
Previous filing
03 Sep 2024
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +2,909 +6.6% $0.000000 47,175 09 Sep 2024 Direct
transaction GH Common Stock Tax liability $29,950 -1,260 -2.7% $23.77 45,915 09 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -2,909 -100% $0.000000 0 09 Sep 2024 Common Stock 2,909 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on September 11, 2020, of which 5,817 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares vest 25% on September 9, 2023, and September 9, 2024.
F3 Not applicable for Restricted Stock Units.